Adaptive Alpha-Non-Alpha Radiation Therapy System

A next-generation radiation therapy system that combines implantable alpha and non-alpha radiation sources with advanced real-time monitoring and adaptive control, enabling personalized and optimized tumor treatment.

The original patent disclosed a method for diffusing alpha-emitter radiation therapy with enhanced beta treatment. However, it had limitations in terms of radiation emission control, tumor response monitoring, and personalized treatment. The new inventive concept addresses these limitations by introducing a system that dynamically adjusts radiation emission based on real-time tumor response monitoring, ensuring more effective and targeted tumor treatment while minimizing healthy tissue damage.

The adaptive radiation therapy system comprises a plurality of implantable radiation sources with combined alpha and non-alpha radiation, a controller, and a real-time tumor response monitoring module. The controller dynamically adjusts the radiation emission of each source based on the monitoring data, using machine learning algorithms to predict and adapt the radiation emission to maximize tumor cell destruction and minimize healthy tissue damage. The system can be integrated with a database of tumor-specific radiation response profiles to enable personalized treatment planning. The radiation sources feature a nanostructured surface coating that amplifies beta radiation emission while minimizing systemic alpha radiation.

The new claims introduce the concept of adaptive radiation therapy, where the radiation emission is dynamically adjusted based on real-time tumor response monitoring. This is a significant departure from the original patent, which did not provide for real-time monitoring and adaptive control. The use of machine learning algorithms to predict and adapt radiation emission is also a novel aspect of the inventive concept.

Alternative embodiments of the inventive concept could include the use of different types of radiation sources, such as brachytherapy seeds or external beam radiation therapy. The system could also be integrated with other imaging modalities, such as MRI or CT scans, to enhance tumor response monitoring. Additionally, the machine learning algorithms could be trained on larger datasets to improve their predictive accuracy.

The adaptive radiation therapy system has significant commercial potential in the radiation oncology market, particularly in the treatment of cancerous tumors. The system's ability to provide personalized and optimized treatment could lead to improved patient outcomes and reduced healthcare costs. The target industries include radiation oncology clinics, hospitals, and medical research institutions.